Trends in annualized relapse rates in relapsing remitting multiple sclerosis and consequences for clinical trial design.
Trends in annualized relapse rates in relapsing remitting multiple sclerosis and consequences for clinical trial design.
Nicholas R, Straube S, Schmidli H, Schneider S, Friede T (2011). Multiple Sclerosis Journal 17: 1211-1217.